Balanced news tone
News Sentiment
QTRX sentiment intelligence
Quanterix Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-10.4% over one week, +25.2% over four weeks, trend inactive, and below fair value.
Quanterix Corporation (QTRX) Gains on Coverage Announcement for Alzheimer's Test
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Quanterix Corporation (QTRX) Gains on Coverage Announcement for Alzheimer's Test
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Jul 2026 14:33
- Source
- GuruFocus
Quanterix wins coverage for Alzheimer’s test (QTRX:NASDAQ)
Quanterix Corporation saw a ~3% increase in premarket trading after announcing that its Alzheimer’s test, LucentAD Complete, will be covered by Elevance Health’s Anthem Blue Cross and Blue Shield health plans starting this month. This coverage is expected to expand access to the
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 15 Jul 2026 12:40
- Source
- Seeking Alpha
Anthem Blue Cross covers Quanterix Alzheimer’s blood test
Anthem Blue Cross and Blue Shield will now cover Quanterix Corporation's LucentAD Complete blood-based biomarker test for Alzheimer's disease for its 40 million members, effective July 1, 2026. This announcement led to a 5% increase in Quanterix's stock. The company also highligh
- Tone
- Positive 69/100
- Event
- Market update
- Published
- 15 Jul 2026 02:40
- Source
- Investing.com
Quanterix (QTRX) Marks Key Milestones in Alzheimer's Testing Adv
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 23:37
- Source
- GuruFocus
Quanterix Advances Adoption of LucentAD Complete Blood Test
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 21:34
- Source
- MT Newswires
Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 20:29
- Source
- Business Wire
Quanterix test found preclinical Alzheimer’s evidence in 20% of cognitively normal adults
Quanterix announced that Anthem Blue Cross and Blue Shield will begin commercial coverage for its LucentAD® Complete blood test for Alzheimer's disease on July 1, 2026. This milestone, alongside a new peer-reviewed study and data presented at AAIC 2026, reinforces the clinical va
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 14 Jul 2026 20:13
- Source
- Stock Titan
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
Director Scott Mendel converts 8,073 RSUs at Quanterix (NASDAQ: QTRX)
Quanterix director Scott Mendel converted 8,073 restricted stock units (RSUs) into common shares on July 8, 2026, as part of a routine vesting event. Following this transaction, he directly holds 24,056 common shares and 16,391 remaining RSUs. The converted RSUs were part of a 24
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 20:40
- Source
- Stock Titan
Quanterix (QTRX) director converts 8,073 RSUs, now holds 15,041 shares
Quanterix Corp director Myla Lai-Goldman converted 8,073 restricted stock units (RSUs) into common shares, increasing her direct holdings to 15,041 shares. She still holds 16,391 RSUs which will convert into common stock on a one-for-one basis. These RSUs were part of a larger gr
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 08:09
- Source
- Stock Titan
Quanterix (QTRX) Stock Fair Value Falls After Analysts Cut Price Targets
- Tone
- Negative 18/100
- Event
- Market update
- Published
- 09 Jul 2026 23:21
- Source
- Market source
Form 4 Quanterix Corp For: 9 July By Investing.com
This article announces the filing of Form 4 for Quanterix Corp on July 9th. It is a brief corporate news update from Investing.com, typical of filings news. The article also includes various market data like indices, commodities, and share prices, along with trending news and sto
- Tone
- Negative 42/100
- Event
- Market update
- Published
- 09 Jul 2026 22:22
- Source
- Investing.com Nigeria
Quanterix (QTRX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary
Quanterix (QTRX) presented at the Goldman Sachs 47th Annual Global Healthcare Conference in 2026, where the company highlighted its strategic shift from research tools to clinical diagnostics, particularly in Alzheimer's. Key points included plans for FDA approval of a multi-mark
- Tone
- Positive 69/100
- Event
- Regulatory and legal
- Published
- 08 Jul 2026 21:10
- Source
- Quartr
Quanterix (QTRX) Q1 2025 earnings summary
Quanterix (QTRX) reported a Q1 2025 revenue of $30.3M, a 5% year-over-year decrease, with record consumables performance offset by softness in other segments, leading to a widened net loss of $20.5M. The company is prioritizing operational discipline and cost reductions to achiev
- Tone
- Negative 33/100
- Event
- Earnings
- Published
- 08 Jul 2026 21:10
- Source
- Quartr
QTRX: Recalibrated Expectations Will Shape Long Term Alzheimer’s Blood Test Upside
Analysts have adjusted their price targets for Quanterix (QTRX), leading to a lower but still supported valuation range, primarily due to recalibrated expectations regarding fair value, discount rates, revenue growth, profit margins, and future P/E multiples. While some analysts
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 Jul 2026 20:17
- Source
- Simply Wall Street
Quanterix (QTRX) director gets 5,472-share stock grant for Q2 2026 board fees
Quanterix (QTRX) director William P. Donnelly received a grant of 5,472 shares of common stock, valued at $4.34 per share, as compensation for his board service in Q2 2026, in lieu of cash fees. This transaction, categorized as a grant/award, increases his direct holdings to 160,
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 06 Jul 2026 08:41
- Source
- Stock Titan
Quanterix (QTRX) director receives 3,456-share stock grant for board service
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Stock Titan
Quanterix Corporation(NasdaqGM: QTRX) dropped from Russell 3000E Growth Benchmark
Quanterix Corporation (NasdaqGM: QTRX) has been removed from the Russell 3000E Growth Benchmark. The article also provides recent news about the company, including management changes, quarterly earnings results, and presentations at financial conferences. It also includes financi
- Tone
- Negative 31/100
- Event
- Earnings
- Published
- 30 Jun 2026 04:39
- Source
- www.marketscreener.com
Quanterix Corporation(NasdaqGM:QTRX) dropped from Russell Small Cap Comp Growth Benchmark
Quanterix Corporation (NasdaqGM:QTRX) has been removed from the Russell Small Cap Comp Growth Benchmark, as announced on June 29, 2026. This news comes alongside several recent updates for the company, including presentations at a Goldman Sachs conference and changes to its execu
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 21:10
- Source
- www.marketscreener.com
Quanterix Corporation Actuals & Estimates (NASDAQ:QTRX)
This article provides an overview of Quanterix Corporation (NASDAQ: QTRX) stock performance, financial actuals, and analyst estimates. It includes current stock price, recent performance trends, market capitalization, earnings estimates, revenue figures, and employee count. The a
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Jun 2026 04:10
- Source
- TradingView
Enterprise value to EBITDA forward of Quanterix Corporation – NASDAQ:QTRX
This article displays the "Enterprise value to EBITDA forward" metric for Quanterix Corporation (NASDAQ: QTRX) on TradingView. It provides financial data for the company under the Health Technology sector. The content itself is an excerpt from a financial data platform, showcasin
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 05:09
- Source
- TradingView
Enterprise value to revenue forward of Quanterix Corporation – NASDAQ:QTRX
This article displays financial information for Quanterix Corporation (NASDAQ: QTRX), specifically its enterprise value to revenue forward metric. It's presented within a TradingView interface, showing market data from various providers like ICE Data Services and FactSet. The con
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Jun 2026 09:11
- Source
- TradingView
QTRX Forecast — Price Target — Prediction for 2027
This article provides a forecast for Quanterix Corporation (QTRX) stock, including analyst price targets and predictions for 2027. It details recent stock performance, financial metrics like EPS and revenue, and upcoming earnings dates. The article also answers frequently asked q
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Jun 2026 08:39
- Source
- TradingView
QTRX - Quanterix Corp Volatility & Greeks
This article provides a detailed financial overview of Quanterix Corp (QTRX), including its stock performance, key financial metrics, and volatility data. It lists various ratios such as P/E, P/S, ROA, and highlights insider and institutional ownership, alongside short interest f
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 05:10
- Source
- Finviz
Quanterix Stock Is Popping In Pre-Market: Here's Why
Quanterix Corporation (NASDAQ: QTRX) stock surged 5.28% in pre-market trading after Securities and Exchange Commission filings revealed outgoing CFO Vandana Sriram vested and forfeited some restricted stock units. Jason Faessler officially assumed the CFO role, joining from Bruke
- Tone
- Positive 60/100
- Event
- Market update
- Published
- 25 Jun 2026 15:39
- Source
- Sahm
Quanterix Corp (QTRX) Valuation: PE, PB & Fair Value Analysis
Quanterix Corp (QTRX) currently holds a valuation score of 7.38, placing it 163rd out of 203 in the Healthcare Equipment & Supplies industry. The company's P/E ratio is -1.83, which is significantly below its recent high and above its recent low. Key valuation metrics like P/B, P
- Tone
- Negative 40/100
- Event
- Market update
- Published
- 25 Jun 2026 14:39
- Source
- TradingKey
Quanterix Corp sets out growth plans, shares trade on Nasdaq
Quanterix Corp is gaining investor attention with its digital biomarker platform and recent operational milestones, with its shares trading on Nasdaq. The company focuses on developing ultra-sensitive digital biomarker assays based on its proprietary Simoa technology, targeting p
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 25 Jun 2026 12:41
- Source
- Ad-hoc-news.de
Price to earnings forward of Quanterix Corporation – NASDAQ:QTRX
This article provides the "Price to earnings forward" metric for Quanterix Corporation (NASDAQ: QTRX). It indicates that the value and change percentages for this financial metric are made by humans and offers some context about the data providers. The main content focuses solely
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 24 Jun 2026 19:40
- Source
- TradingView
Quanterix (QTRX) CFO adds stock as RSUs vest and shares withheld
Quanterix CFO Vandana Sriram reported that 1,833 restricted stock units (RSUs) converted into common stock on June 15, 2026. Of these, 548 shares were withheld at $3.10 per share to cover tax obligations, which is a routine part of equity compensation. Following these transaction
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 14:39
- Source
- Stock Titan
TRIB, QTRX, RCON: Why These Stocks Are Surging After-Hours Today
Trinity Biotech (TRIB), Quanterix Corp. (QTRX), and Recon Technology (RCON) all experienced double-digit gains in after-hours trading. TRIB surged after launching Trinovium, a new subsidiary for liquid-cooling solutions for AI data centers. QTRX rose following the official appoin
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:40
- Source
- Stocktwits